Corrigendum to "Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications"

A Quintanal-Villalonga^{1

2}, Luis Paz-Ares^{1

2

3}, Irene Ferrer^{1

2}, S Molina-Pinelo^{1

2}

Affiliations

¹ Medical Oncology Department, Hospital Universitario Doce de Octubre, 28041 Madrid, Spain.
² Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.
³ University of Seville, Seville, Spain.

Published Erratum

A Quintanal-Villalonga et al. Dis Markers. 2018.

. 2018 Jul 19:2018:3714684.

doi: 10.1155/2018/3714684. eCollection 2018.

A Quintanal-Villalonga^{1

2}, Luis Paz-Ares^{1

2

3}, Irene Ferrer^{1

2}, S Molina-Pinelo^{1

2}

¹ Medical Oncology Department, Hospital Universitario Doce de Octubre, 28041 Madrid, Spain.
² Centro Nacional de Investigaciones Oncológicas (CNIO), 28029 Madrid, Spain.
³ University of Seville, Seville, Spain.

Abstract

[This corrects the article DOI: 10.1155/2016/9214056.].

Tyrosine Kinase Receptor Landscape in Lung Cancer: Therapeutical Implications.
Quintanal-Villalonga A, Paz-Ares L, Ferrer I, Molina-Pinelo S. Quintanal-Villalonga A, et al. Dis Markers. 2016;2016:9214056. doi: 10.1155/2016/9214056. Epub 2016 Jul 26. Dis Markers. 2016. PMID: 27528792 Free PMC article. Review.

1. Quintanal-Villalonga A., Paz-Ares L., Ferrer I., Molina-Pinelo S. Tyrosine kinase receptor landscape in lung cancer: therapeutical implications. Disease Markers. 2016;2016:14. doi: 10.1155/2016/9214056.9214056 - DOI - PMC - PubMed